BEND5 and colorectal carcinoma: In the present study, the BEND5 promoter and exon 1 regions were hypermethylated only in the CRC tumors, but not in the matched colon tissues (Figures 1–3), suggesting that BEND5 hypermethylation may be a biomarker of CRC.